ACCLPP’s Current Activities
The current charter of the Advisory Committee on Childhood Lead Poisoning Prevention expired on October 31, 2013. The ACCLPP has provided CDC and the Department of Health and Human Services with extremely valuable scientific and technical advice related to the prevention of childhood lead poisoning.
CDC is committed to childhood lead poisoning prevention; to address this important public health concern, CDC established the Lead Poisoning Prevention Subcommittee of the NCEH/ATSDR Board of Scientific Counselors in March 2015. The subcommittee was established to provide expertise on public health policies and practices relevant to lead poisoning prevention and to conduct preparatory research, analysis, and other developmental activities involving more detailed work that cannot be practically accomplished by the full Board of Scientific Counselors.
Recommendations
-
Guidelines for Measuring Lead in Blood Using Point of Care Instruments [PDF - 472 KB]
Fact Sheet: Blood Lead Levels in Children - Important Information for Parents [PDF - 168 KB]
January 4, 2012 Agenda [PDF - 183 KB]
Recommendations of the Advisory Committee for Childhood Lead Poisoning Prevention [PDF - 890 KB]
-
Recommendations for Interagency Working Group on Import Safety
This letter contains the Department of Health and Human Services’ Advisory Committee on Childhood Lead Poisoning Prevention’s recommendations to reduce health hazards posed by the presence of elevated levels of lead in children’s jewelry, clothing ornaments, and paint applied to children’s toys.
Work Groups
The ACCLPP has five work groups. Work groups provide the ACCLPP with new and updated information about priority childhood lead poisoning prevention issues. A work group meets as necessary to accomplish its goals. Descriptions of the current work groups follow.-
Blood Lead Level of Concern Workgroup
The Blood Lead Level of Concern Workgroup is charged with re-evaluating levels of lead in blood that are related to adverse health effects, based on the current scientific literature. The workgroup will also recommend how to best replace the ‘level of concern’ in relation to accumulating scientific evidence of adverse effects of <10 ug/dl blood lead in children and adults. Potential approaches that can be considered include defining elevated levels as those exceeding reference values, undertaking a standard risk assessment based on reported adverse effect levels, or utilizing an existing risk assessment prepared by others. The workgroup will also consider laboratory quantification for lead in blood as a possible limitation in establishing new guidance.
-
Educational Interventions for Lead-Exposed Children Work Group
The Educational Interventions for Lead Exposed Children Work Group (working title “Assessments and Educational Interventions Work group” ) will update ‘Managing Elevated Blood Lead Levels Among Young Children: Chapter 5 Developmental Assessment and Intervention’ published in 2002. Read more about the Educational Interventions for Lead-Exposed Children Work Group charge.
-
The Laboratory Work Group is charged with investigating and reporting on five issues: proficiency testing (PT) limits; practice standards for point of care lead testing; alternative matrices for assessing exposure to lead; environmental lead analytical issues; and, reference intervals for adult lead exposure. Read more about the Laboratory Work Group charge.
-
Lead in Consumer Products Work Group
To advance the public health goal of reducing the contribution of consumer products to childhood lead exposure, the Lead in Consumer Products Work Group is charged with building upon the formal liaisons that now exist between the CDC Advisory Committee on Childhood Lead Poisoning Prevention and other federal agencies, as well as working with parties in the public and private sector to pursue efforts that support the convening of an international conference that addresses advances in the recognition, management, and prevention of lead poisoning in children and adults. Read more about the Lead in Consumer Products Work Group charge.
-
The Lead and Pregnancy Work Group will review the existing evidence for adverse effects of past and current maternal lead exposure on maternal fertility and on the developing fetus, infant and child in prenatal and postnatal states. The work group will then evaluate the data and issue recommendations. Read more about the Lead and Pregnancy Work Group charge.
- Page last reviewed: June 1, 2009
- Page last updated: September 7, 2016
- Content source:
National Center for Environmental Health, Division of Emergency and Environmental Health Services